Nutex Health (NUTX) director buys shares and converts 116 RSUs

Rhea-AI Filing Summary

Nutex Health director Kelvin Spears reported a small open-market share purchase and an RSU-related stock acquisition. The filing also corrects his previously reported RSU holdings.

On March 17, 2026 he bought 10 common shares at $94.46, bringing his direct stake to 32,137 shares. A March 10, 2026 derivative transaction converted 116 restricted stock units into common stock, and 339 RSUs are now reported as beneficially owned following the correction.

Insider Trade Summary

Net Buyer: 10 shares ($945)

Net Buy 2 txns

Insider Spears Kelvin

Role Director

Bought 10 shs ($944.60)

Type	Security	Shares	Price	Value
Purchase	Common Stock	10	$94.46	$944.60
Exercise	Restricted Stock Unit	116	$0.00	--

Holdings After Transaction: Common Stock — 32,137 shares (Direct); Restricted Stock Unit — 339 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spears Kelvin

(Last) (First) (Middle)

1776 YORKTOWN STREET

C/O NUTEX HEALTH INC

(Street)

HOUSTON TEXAS 77056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		P		10	A	$94.46	32,137	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	$0	03/10/2026		M		116		03/01/2027	03/01/2029	Common Stock	116	$0	339(1)	D

Explanation of Responses:

1. This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

	/s/ Kelvin Spears	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Nutex Health (NUTX) director Kelvin Spears report?

Kelvin Spears reported two transactions: an open-market purchase of 10 Nutex Health common shares and a derivative transaction converting 116 restricted stock units into common stock. The filing also updates his reported RSU holdings after correcting a prior Form 4 entry.

How many Nutex Health (NUTX) shares does Kelvin Spears own after these transactions?

After the reported transactions, Kelvin Spears directly owns 32,137 Nutex Health common shares. The Form 4 also shows he beneficially owns 339 restricted stock units, reflecting a corrected balance following the RSU grant initially reported in a Form 4 filed on March 11, 2026.

What price did Kelvin Spears pay for Nutex Health (NUTX) shares?

Spears purchased 10 Nutex Health common shares in the open market at $94.46 per share. This was a relatively small buy compared with his overall reported holdings, which now total 32,137 common shares owned directly following the reported transaction.

What does the RSU transaction in the Nutex Health (NUTX) Form 4 represent?

The RSU transaction reflects the exercise or conversion of 116 restricted stock units into Nutex Health common stock. The filing clarifies that, after this RSU grant and related correction, Spears beneficially owns 339 RSUs, updating the amounts previously reported for the March 10, 2026 grant.

Why does the Nutex Health (NUTX) Form 4 mention a correction to RSU holdings?

A footnote explains the Form 4 corrects the number of restricted stock units Spears beneficially owned after the RSU grant dated March 10, 2026. It updates the earlier Form 4 filed March 11, 2026, ensuring the RSU balance now accurately reflects 339 units.